With deals in the protein degradation market reaching nearly $2 billion and unique degradation ideas coming into play such as LYTACs and ENDTACs, eyes are focused on how much further protein degradation-based therapeutics will continue to grow within the pharmaceutical industry. Following huge success in May 2019, the 2nd European Protein Degradation Congress, returns on 28th […]

The inaugural Gene Therapy for Inherited Metabolic Disorders Summit will put the spotlight on the understanding of topics from the physiopathology of disease through to the nuances of dosing and delivery methods and designing a trial with endpoints and outcome measures that are meaningful both clinically and to patients. Join 60+ industry leaders across the […]

Accelerating the Development of Gamma Delta T Therapies in Oncology Join us on Wednesday, September 30, to discuss the precise mechanisms of γδT cells, examine donor selection for allogeneic therapies, and deliberate the targeting of solid tumours. As we virtually gather world-leading researchers at the Gamma Delta T Therapies Summit, learn how the industry is […]

The Digital 5th PREDiCT: 3D Oncology & Tissue Models Summit will return this September, with defined tracks and a fresh speaker line-up, bringing together preclinical scientists to discuss adoption and commercialization of 3D models as an integral part of drug development study. This event is completely free for Drug Developers, Researchers and Academics. To register your complimentary […]

Built with insights from the likes of AbbVie, Sanofi, Amgen and Takeda; CDD for Biologics Summit has been specifically designed to help biopharma companies define strategies to further adapt computational tools, mitigate data availability issues and address computational-experimental challenges to add immediate value to their biologics pipelines. This dedicated platform will enable you to address […]

HOSTED BY: HEUFT LED BY: DAN MCKEE General Manager, HEUFT USA Inc Dan McKee is the General Manager of HEUFT USA. He has spent 25 years working with high-speed quality control inspection equipment in the packaging industry. In doing so, he’s become well versed in non-destructive techniques for testing a wide variety of package attributes […]

This conference offers experts working in the biopharmaceutical industry as well as academia the opportunity to examine the latest developments in the field with dedicated congress presentations, panel discussions and roundtables. The agenda will explore : Novel methods, research techniques, advances and discoveries in the field. Research applications utilizing technologies such as qPCR, Digital PCR […]

As a vital tool for providing quantifiable data on cell characteristics, flow cytometry is an integral part of diagnostics and the assessment of therapeutic efficacy. Talks will also explore the application of flow cytometry in disease monitoring and diagnosis, and approaches to implementation in the clinic. The meeting will focus on: Advances in flow cell […]

qPCR & Digital PCR are the most essential techniques used for quantification of nucleic acid molecules in molecular biology and diagnostics. Where qPCR is considered as a powerful technique that can provide precise and quantitative data reflecting the biology of the tested experimental parameters, the excellent precision of dPCR supports its application for the detection […]

Animal Health Investment USA is a premier investment forum showcasing the most exciting partner opportunities in animal health and connecting those businesses together with financial investors and strategic corporate partners. Once again, our forum in Boston will be split into two tracks, a human biotech and animal health partnering track and an investor track. The […]

Off the back of the newly released first-in-human data utilizing PROTACs, it is more than ever evident that the field of targeted protein degradation is redefining the therapeutic landscape across the whole of the pharmaceutical industry. Despite the recent success, significant challenges are continuing to hold back the progress of the discovery and development of safe […]

The Congress will explore novel strategies and developments in plant genomics and gene editing through a series of case studies and an examination of the latest scientific research. Leaders from academia and industry will consider key developments in gene editing technologies such as CRISPR/Cas9 and TALEN and discuss its application in improving disease resistance, stress […]

Case studies across the two days will examine developments in biopesticides and biostimulants and the application of new research in increasing crop yield, improving soil health & nutrient uptake, and efficient water use. Experts from industry and academia will also discuss pest management strategies and provide regulatory updates in the field. Discover how research institutions […]

The 5th Microbiome Movement – Drug Development Summit (October 19-21, Digital Event - EDT) continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical, biotech and academic community pursue the causal role of the human microbiome in disease, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable […]

The meeting will examine the symbiotic relationships between microbes and plants through case studies in plant and soil microbiomes. Academic and industry leaders will discuss new research into the rhizosphere, phyllosphere and endosphere and the application of plant and soil microbiome research in improving disease resistance, nutrient acquisition and crop yield, and tolerance to multiple […]

After the challenges of 2020 with the Covid-19 pandemic, this is the unmissable event that the pharmaceutical, biotechnology, and medical device communities need to come together and discuss strategies for operational success in clinical trials. With all the latest content, and a big focus on the latest regulations and technology, the conference will offer an […]

SMi are proud to announce the 7th annual conference: Pre-Filled Syringes East Coast 2020 26-27 October 2020 Boston, USA Sheraton Boston Hotel http://www.pfsamericas.com/pjwl Innovations in parenteral device and product development SMi Group are proud to announce the 7th Pre-Filled Syringes East Coast conference returning to Boston, USA on 26th-27th October 2020. The global pre-filled syringes market was valued at […]

Priming the immune system against solid tumors by leveraging immune checkpoint blockade has proven to be an effective tool in multiple malignancies. Following the success of PD1/PDL1 checkpoint inhibitors a new wave of ICI now enters the clinic, amongst which TIGIT has shown exciting preliminary results and sparked great excitement in this nascent field. With 27 […]

Smithers’ 9th annual Extractables and Leachables USA conference is returning. This is a unique event in the extractables and leachables industry, bringing together top companies from the entire supply chain and making it easy to network with peers, leading to new, beneficial connections. The event is a must for the extractables and leachables industry, wherein players need […]

Realise the Commercial Potential of Gene Therapies The 4th Annual Gene Therapy for Rare Disorders Europe is dedicated to overcoming manufacturing, clinical, and commercialisation challenges drug developers face when delivering gene therapies to market. With new European gene therapy approvals rapidly approaching and investment at an all-time high, the digital meeting will leverage the experience from the first to market pioneers, as […]

Harnessing the Potential of Macrophage Therapies Using Small Molecule, Antibody & Cell Therapy based Approaches for Oncology and Beyond With the explosive excitement and clinical proof of concepts utilizing CD47 approaches, macrophage-directed therapies have started to witness interest and investment in novel macrophage targets outside of CD47. The 2nd Macrophage-directed Therapies Summit is focused on […]

Priming the immune system against solid tumors by leveraging immune checkpoint blockade has proven to be an effective tool in multiple malignancies. Following the success of PD1/PDL1 checkpoint inhibitors a new wave of ICI now enters the clinic, amongst which TIGIT has shown exciting preliminary results and sparked great excitement in this nascent field. With 27 […]

SMi’s 3rd Annual Pharmaceutical Microbiology East Coast Conference: 28 – 29 October 2020 Location: Virtual Event Website: www.microbiologyeastcoast.com/PJWL SPONSORED BY: Associates of Cape Cod, bioMérieux, Bioscience International, C.T.L. MAT, LONZA CHAIRED BY: Lynne Ensor,VP Technical, Parexel Exploring the current approaches towards improved contamination control The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With […]

Finding new therapeutics to counter the progression of Dry AMD and prevent the geographical atrophy has never been more important. The aging population creates an ever-growing clinical need for next-generation therapeutics. This action-packed two-day digital agenda holds 22 Presentations from industry and academic leaders, a virtual poster session and 5+ hours of networking, you can join the only […]

Achieving Standardization & Operational Excellence in Vein-to-Vein Supply As an increasing number of candidates enter the clinic and promise to be a mainstay in the future of cancer treatment, cell therapies pose unique supply chain challenges. At the inaugural Patient-to-Patient Supply for Cell Immunotherapies Summit, this community will share their expertise and propose best practice […]